Australia, Jan. 21 -- Dhun Aus Pty Ltd (ACN: 676319010) has issued a ‘NOTICE OF APPOINTMENT AS LIQUIDATOR - 491(2)(b)’ on Jan. 21. The following are other related details: Status: In Liquidation App... Read More
Australia, Jan. 21 -- M JACKC Management Services Pty Ltd (ACN: 673768860) has issued a ‘NOTICE OF APPLICATION FOR WINDING UP ORDER - 465A(1)(c)’ on Jan. 21. The following are other related details: ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357597) titled 'An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357766) titled 'A Research Study to Compare Different Versions of Injectable CagriSema and Plac... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07362056) titled 'Implementing Suicide Prevention Into Primary Care in Nepal' on Jan. 21. Study ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000081314) titled 'Daridorexant treatment in adults with migraine and insomnia: an explora... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357740) titled 'A Research Study to Compare Two Different Versions of Injectable CagriSema in P... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357701) titled 'Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ova... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07359807) titled 'A Prospective, Randomized, Multi-center Trial Comparing the MagicTouch PTA Siro... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07359859) titled 'A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With ... Read More